With two approvals in one day, Regeneron could be headed higher

Bull Market - Financial Data

Bull Market - Financial Data


Regeneron CEO Leonard Schleifer and President George Yancopoulos likely went to bed Friday night as two very happy individuals. After all, the biopharma they founded garnered not one, but two US FDA approvals the same day.

On Friday, the agency approved the company’s Veopoz (pozelimab)followed by high-dose (“HD”) Eylea

Leave a Reply

Your email address will not be published. Required fields are marked *